EIF3A and breast cancer: A higher mRNA expression of EIF3A/ I/ M showed better RFS in patients with breast cancer (Figure 3(b), HR = 0.8, 95% CI: 0.72–0.89, P < 0.001; Figure 3(h), HR = 0.87, 95% CI: 0.78–0.97, P < 0.05; Figure 3(k), HR = 0.76, 95% CI: 0.68–0.85, P < 0.001).